Terms: = Head and neck cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Clinical Outcome
8 results:
1. Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.
Trada Y; Keall P; Jameson M; Moses D; Lin P; Chlap P; Holloway L; Min M; Forstner D; Fowler A; Lee MT
Eur Radiol; 2023 Dec; 33(12):8788-8799. PubMed ID: 37405500
[TBL] [Abstract] [Full Text] [Related]
2. Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy.
Sörensen A; Carles M; Bunea H; Majerus L; Stoykow C; Nicolay NH; Wiedenmann NE; Vaupel P; Meyer PT; Grosu AL; Mix M
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1056-1064. PubMed ID: 31773233
[TBL] [Abstract] [Full Text] [Related]
3. Dosimetric analysis and clinical outcomes of brachial plexus as an organ-at-risk in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
Prakash BB; Yathiraj PH; Sharan TK; Singh A; Reddy AS; Chandraguthi SG; Subramanian RB; Nagesh J; Nair SS; Fernandes DJ; Mamidipudi VS
J Cancer Res Ther; 2019; 15(3):522-527. PubMed ID: 31169214
[TBL] [Abstract] [Full Text] [Related]
4. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
Kendi AT; Corey A; Magliocca KR; Nickleach DC; Galt J; Switchenko JM; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
[TBL] [Abstract] [Full Text] [Related]
5. clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392
[TBL] [Abstract] [Full Text] [Related]
6. 3'-Deoxy-3'-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients.
Idema AJ; Hoffmann AL; Boogaarts HD; Troost EG; Wesseling P; Heerschap A; van der Graaf WT; Grotenhuis JA; Oyen WJ
J Nucl Med; 2012 Dec; 53(12):1904-10. PubMed ID: 23077112
[TBL] [Abstract] [Full Text] [Related]
7. Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
Castaldi P; Rufini V; Bussu F; Miccichè F; Dinapoli N; Autorino R; Lago M; De Corso E; Almadori G; Galli J; Paludetti G; Giordano A; Valentini V
Radiother Oncol; 2012 Apr; 103(1):63-8. PubMed ID: 22459579
[TBL] [Abstract] [Full Text] [Related]
8. Impact of FDG-PET on prediction of clinical outcome after concurrent chemoradiotherapy in hypopharyngeal carcinoma.
Inohara H; Enomoto K; Tomiyama Y; Higuchi I; Inoue T; Hatazawa J
Mol Imaging Biol; 2010; 12(1):89-97. PubMed ID: 19421820
[TBL] [Abstract] [Full Text] [Related]
